Specifically, present in stool samples, the reported fecal biomarkers for IBD primarily include fecal leukocyte proteins, such as calprotectin, calgranulin C, lactoferrin, and lipocalin-2 (Table 4). This evidence concerns the gene LTF and inflammatory bowel disease.